Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuval Tal

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
The Journal of Allergy and Clinical Immunology. in Practice|July 2, 2023
Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for AnaphylaxisYuval Tal, Yaarit Ribak, Limor Rubin, et al.
Clinical and Experimental Immunology|June 11, 2021
Chronic demodicosis in patients with immune dysregulation: An unexpected infectious manifestation of Signal transducer and activator of transcription (STAT)1 gain-of-functionOded Shamriz, Atar Lev, Amos J Simon, et al.
Frontiers in Immunology|January 6, 2023
Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experienceOded Shamriz, Limor Rubin, Amos J Simon, et al.
The Journal of Allergy and Clinical Immunology. Global|March 11, 2026
Severe eosinophilia and risk of major disease and mortality: A nationwide cohort study of children and adultsShay Nemet, Daniel Elbirt, Ramon Cohen, et al.
Frontiers in Immunology|January 23, 2026
NDUFS4, a mitochondrial complex I subunit, is essential for T-cell metabolic fitness and immune functionOded Shamriz, Zahala Bar-On, Omri Yosef, et al.
Journal of Clinical Immunology|August 1, 2025
β-Actin Deficiency in Baraitser-Winter Syndrome Type 1 Disrupts T-Cell Function and Immune Regulation: Implications for Targeted Therapy in ActinopathiesZahala Bar-On, Or Reuven, Atar Lev, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 10, 2017
Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patientsZahava Vadasz, Yuval Tal, Menachem Rotem, et al.
Journal of Clinical Immunology|January 17, 2024
Management of Atopy with Dupilumab and Omalizumab in CADINS DiseaseNatalie M Diaz-Cabrera, Bradly M Bauman, Mildred A Iro, et al.
Med (New York, N.Y.)|June 18, 2022
B cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B cells and SARS-CoV-2 neutralizing antibodiesIlana Fox-Fisher, Sheina Piyanzin, Mayan Briller, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The Journal of Allergy and Clinical Immunology. in Practice|July 2, 2023
Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for AnaphylaxisYuval Tal, Yaarit Ribak, Limor Rubin, et al.
Clinical and Experimental Immunology|June 11, 2021
Chronic demodicosis in patients with immune dysregulation: An unexpected infectious manifestation of Signal transducer and activator of transcription (STAT)1 gain-of-functionOded Shamriz, Atar Lev, Amos J Simon, et al.
Frontiers in Immunology|January 6, 2023
Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experienceOded Shamriz, Limor Rubin, Amos J Simon, et al.
The Journal of Allergy and Clinical Immunology. Global|March 11, 2026
Severe eosinophilia and risk of major disease and mortality: A nationwide cohort study of children and adultsShay Nemet, Daniel Elbirt, Ramon Cohen, et al.
Frontiers in Immunology|January 23, 2026
NDUFS4, a mitochondrial complex I subunit, is essential for T-cell metabolic fitness and immune functionOded Shamriz, Zahala Bar-On, Omri Yosef, et al.
Journal of Clinical Immunology|August 1, 2025
β-Actin Deficiency in Baraitser-Winter Syndrome Type 1 Disrupts T-Cell Function and Immune Regulation: Implications for Targeted Therapy in ActinopathiesZahala Bar-On, Or Reuven, Atar Lev, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 10, 2017
Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patientsZahava Vadasz, Yuval Tal, Menachem Rotem, et al.
Journal of Clinical Immunology|January 17, 2024
Management of Atopy with Dupilumab and Omalizumab in CADINS DiseaseNatalie M Diaz-Cabrera, Bradly M Bauman, Mildred A Iro, et al.
Med (New York, N.Y.)|June 18, 2022
B cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B cells and SARS-CoV-2 neutralizing antibodiesIlana Fox-Fisher, Sheina Piyanzin, Mayan Briller, et al.
Pageof 8